(NaturalNews) Eli Lilly’s multibillion-dollar acquisition of a company developing experimental psychedelic therapies marks the largest investment yet by a drugmaker…
Pharma Eyes Psychedelics Market as Patients Seek New Depression Treatments
Estimated read time
1 min read
